In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes

FAS inhibition by flavonoids and their derivatives may offer significant potential as an approach to lower the risk of various cancer diseases and related fatalities. In silico technologies with available FAS crystal structures may be of significant use in optimizing preliminary leads.